TEE
AMPE

Tibra Equities Europe’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Tibra Equities Europe’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-574
Closed -$585K – 236
2018
Q1 		$585K Buy
+574
New +$481K 0.1% 111

Other funds holding AMPE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return

Tibra Equities Europe's AMPE Position: Q2 2018 in Review

Tibra Equities Europe sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2018, closing a stake of 574 shares — an estimated $585K sold.

Tibra Equities Europe first reported a position in AMPE in Q1 2018 and held it in 1 quarter. The position peaked at $585K in Q1 2018. 86 funds tracked by Wall St. Rank hold AMPE as of Q2 2018.

  • Tibra Equities Europe reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2018 after selling out during the quarter.
  • Tibra Equities Europe sold 574 Ampio Pharmaceuticals Inc. shares in Q2 2018, an estimated $585K.
  • Tibra Equities Europe first reported a position in Ampio Pharmaceuticals Inc. in Q1 2018 and held it in 1 quarter.
  • Tibra Equities Europe's Ampio Pharmaceuticals Inc. position peaked at $585K in Q1 2018.
  • 86 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2018.

Based on Tibra Equities Europe's 13F filing for Q2 2018, filed 10 Aug 2018.